19th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicin

UNFPA
19th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicin Request for EOI

Reference: UNFPA/DNK/EOI/25/021
Beneficiary countries or territories: Multiple destinations (see 'Countries' tab below)
Published on: 26-Feb-2025
Deadline on: 26-Mar-2025 17:00 (GMT 0.00)

Description

19th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health MedicinesProducts of Interest including new categories:

Injectable hormonal contraceptives

Depot medroxyprogesterone acetate 104mg/0.65ml (DMPA-SC)1

Attention: Linda Serwaa

Deadline for submissions:

Electronic documentation to be emailed by Monday  10 March  2025, at 17:00 (Copenhagen time).

Sample submissions must reach the UNFPA reception in Copenhagen by Monday, 28 March 2025, at 17:00 (Copenhagen time).

contact details

Any questions related to the review processes should be addressed to Ms. Linda Serwaa at serwaa@unfpa.org.